Industrial development in the U.S. is off to a slow start in 2025, but that could change thanks to a manufacturing expansion expected to boost numbers soon, according to a new report from Yardi’s ...

MacroGenics agreed to sell its GMP manufacturing operations to Bora Pharmaceuticals in a deal designed to strengthen its ...

Hikma Pharmaceuticals USA will invest $1 billion by 2030 to further expand its U.S. manufacturing and R&D capabilities. This new phase of investment -- America Leans on Hikma: Quality Medicines ...

The push to reshore and otherwise grow U.S. manufacturing space is in full swing, as private companies look to avoid supply chain disruptions and public policy supports its expansion as a matter of ...

Dozens of manufacturing leaders gathered Wednesday near Pittsburgh International Airport to break ground on a second ...

China's manufacturing development ranks among top tier in the world during the 2020-22 period, showcasing resilience with a stable growth, according to a report released on Thursday. Analysts pointed ...

IQ Consortium representatives explore industry approaches and practices for applying GMPs in early development. The International Consortium on Innovation and Quality in Pharmaceutical Development (IQ ...

Approval of breakthrough therapies requires expedited quality assessment. FDA’s success in speeding the approval of new drugs and biologics for patients suffering from serious diseases reflects ...